JuRexMaximus

Clinical Trials Professional • He/Him • 🇵🇭🇬🇧🇲🇽

[BiopharmIQ by Amp @BiopharmIQ]

$QURE surged +78% 🟢after a major FDA position shift on AMT-130 in Huntington’s disease.

So what happened before the reversal?

🔍 We ran the due diligence through the BPIQ API:
» FDA previously viewed the Ph1/2 data as insufficient to support accelerated approval
» $QURE gapped down ~66%🔴 on that news
» 3yr data now supports accelerated approval BLA
» BLA targeted for Q3 2026
» First-ever RMAT in HD

Market snapshot:
» Last: $48.16 vs prior close $26.99
» 52-wk range: $8.73 to $71.50

Same data. Two opposite FDA calls.

BPIQ API shows the full arc, not just the headline.

Build it into your workflow:
https://t.co/6cBmrHrbxG

[BiopharmIQ by Amp @BiopharmIQ]

✅ $SPRO wins FDA approval

• Utebzi (tebipenem pivoxil) approved for cUTI
• First oral carbapenem approved in U.S.
• Phase 3 data demonstrated non-inferiority to IV imipenem-cilastatin
• Priority Review + Fast Track + QIDP

[BiopharmIQ by Amp @BiopharmIQ]

$OTLK up 35% today! 📈

FDA accepted its resubmitted BLA for ONS-5010/LYTENAVA in wet AMD.

Review is now on the clock, with a PDUFA target action date set for July 29, 2026.

Want to track the exact FDA date and other upcoming PDUFAs? Check the comment below 👇

[BiopharmIQ by Amp @BiopharmIQ]

📢 Biotech Stock News 6/17 @ Open

$QURE 75% BLA Submission Plan for AMT-130
$ELTX 23% ELI-002 Complete Responses
$DYN 12% Expanded Debt Facility of $400M
$CVM 10% Closing of Offering
$ABCL 10% Collaboration w/ AbCellera
$VSTM 8% Multiple Pipeline Updates
$RZLT 7% Ersodetug Clinical Program Results
$AVLN 7% Target Enrollment in Ph2b Trial
$OCUL 6% FDA Alignment on AXPAXLI NDA
$RIGL 6% VEPPANU Licensing Agreement
$MIRA 4% Submits Ph2a for Ketamir-2
$JAZZ 1% Late-Breaking Data on Xywav®

$ASRT 0% Merger Completion + Fundamental Change

$ADPT -2% Prices $300M Convertible Notes

Full details in the image + comments 👇

More biotech catalysts: https://t.co/dOvDKOsl7X

[BiopharmIQ by Amp @BiopharmIQ]

📢 M&A News: Zydus Completes Acquisition of $ASRT

Deal Terms
» $23.50/sh all-cash (~$166.4M total consideration)
» Premium: ~75.8% to unaffected close
» $ASRT delisted from Nasdaq post-close

Lead Asset
» ROLVEDON® (eflapegrastim-xnst)
» Type: long-acting G-CSF biologic
» Indication: febrile neutropenia prevention in chemo-treated cancer pts
» Stage: FDA-approved / marketed

Commercial Signal
» Once per chemotherapy cycle dosing
» Adds oncology supportive-care portfolio
» Brings U.S. specialty onco commercial infrastructure

Strategic Fit
» Expands Zydus’ U.S. specialty oncology footprint
» Assertio now a wholly owned Zydus subsidiary

[JuRexMaximus @JuryRex]

@louietbautista Booom

[Neil Stone @DrNeilStone]

I've never been at a medical conference where the results have been greeted with a standing ovation

Tremendous breakthrough in pancreatic cancer treatment

Through science

Hard work, rigorous research, clinical trials.

Science

Not the quack pseudoscience of social media

[Jake Wintermute 🧬/acc @SynBio1]

A use case of scientific AI I hadn't considered

- Retroactively comb the literature for obvious mistakes like this

- Delete from the scientific corpus all the bad papers and all the papers citing them

- Re-train AI on a better dataset than the one humans have been reading

[Sholto David @addictedtoigno1]

Today I'm posting a new blog about an astonishing scientific own goal. Hundreds of papers have reported using a completely wrong antibody to investigate the tumor suppressor p16. This mistake has happened because scientists have muddled the names of two proteins 🧵

[JuRexMaximus @JuryRex]

@ABSCBNNews Lol suot suot pa kayo ng Filipino inspired damit para mapakita na "representation kayo ng Pinas" ulol.

[JuRexMaximus @JuryRex]

@PhilippineStar Di ka na diyan lalabas Bato good luck hehe
Itong mga Chinador na to nakoo hehe

[JuRexMaximus @JuryRex]

@AngelOfPeaceTea @jaicabajar Sinayang mo 18mins ng buhay ko para panuorin yung hearing FAKE NEWS po ikaw.

Kitang kita na denied ang petition niya at pinapabalik yung ~73 million.

Source: https://t.co/m1muFkx33k

[JuRexMaximus @JuryRex]

@MamaPiaya Sinayang mo 18mins ng buhay ko para panuorin yung hearing FAKE NEWS ka!!!

Kitang kita na denied ang petition niya at pinapabalik ang ~73 million.

Source: https://t.co/m1muFkx33k

[Reads with Ravi @readswithravi]

what is real happiness?

[JuRexMaximus @JuryRex]

Puweds na ba siya sabunutan haha

[JuRexMaximus @JuryRex]

Ang hirap naman gumalaw 💃💃

[JuRexMaximus @JuryRex]

So big ng building na to 😬

[JuRexMaximus @JuryRex]

Nagulat siya 👀🙊

[JuRexMaximus @JuryRex]

Thoughts lang while kumakayod,

Ang ugly bruh…🙂‍↔️

[JuRexMaximus @JuryRex]

Hmm…wrong move, wrong move